Table 2.
Effects of the TSST among placebo-treated individuals. Data represent mean±SEM at baseline (pre-stress) and immediately after the TSST (post-stress).
| Measure | Pre-stress | Post-stress | t(df) |
|---|---|---|---|
| Systolic Blood Pressure (mm Hg) | 115.8 ± 3.1 | 130.3 ± 2.9 | −8.0(15)*** |
| Diastolic Blood Pressure (mm Hg) | 64.1 ± 1.6 | 70.2 ± 2.2 | −2.8(15)* |
| Plasma Cortisol (ug/dl) | 7.9 ± 0.8 | 14.7 ± 1.1 | −5.3(15)*** |
| Plasma ACTH (pg/ml) | 16.4 ± 1.4 | 28.6 ± 5.4 | −2.4(13)* |
| Noradrenaline (ng/ml) | 173.0 ± 15.5 | 347.6 ± 43.4 | −5.4(14)*** |
| Progesterone (ng/ml) | 0.6 ± .04 | 0.7 ± .06 | −2.5(12)* |
| STAI | 35.0 ± 2.4 | 46.1 ± 2.6 | −4.4(15)*** |
| POMS Anger | 0.2 ±.09 | 0.5 ± 0.1 | −3.4(15)** |
| POMS Arousal | 0.6 ± 0.3 | 1.3 ± 0.4 | −2.1(15)* |
| POMS Confusion | 0.6 ± 0.2 | 1.2 ± 0.2 | −2.6(15)* |
| POMS Depression | 0.4 ±0.2 | 0.8 ± 0.3 | −2.6(15)* |
| Heart Rate Baseline | 71.5 ± 2.4 | 89.9 ± 3.8 | −7.2(14)*** |
*
indicates a significant difference between pre- and post-stress measurements (Student’s paired t-test, *p<0.05, **p<0.01, ***p<0.001).